Methods of manufacturing topical compositions and apparatus for the same
View Patent ↗Provided according to some embodiments of the invention are methods of manufacturing a pharmaceutical composition. In some embodiments, such methods include homogenizing at a first excipient composition that includes a viscosity agent and at least one solvent to form a first premix composition; separately homogenizing at least one active pharmaceutical ingredient (API) and a second excipient composition to form a second premix composition; and combining the first premix composition and the second premix composition to form the composition. The pre-mixing of constituents may increase the stability of the API and provide uniformity of the dispersion of the constituents throughout the final topical composition.
1. A method of manufacturing a pharmaceutical composition comprising:
homogenizing a first excipient composition comprising at least one viscosity agent and at least one solvent selected from the group consisting of isopropyl alcohol, ethanol, and a combination thereof in an amount of about 50% to about 90% by weight of the pharmaceutical composition to form a first premix composition, wherein the first premix composition is a suspension:
separately mixing at least one active pharmaceutical ingredient (API) and a second excipient composition to form a second premix composition, wherein the at least one API comprises nitric oxide-releasing particles comprising diazeniumdiolate-functionalized co-condensed silica and the second premix composition is a suspension:
combining the first premix composition and the second premix composition; and homogenizing the combined first premix composition and second premix composition to form the pharmaceutical composition,
wherein a homogenizer is used to form the first premix composition and to homogenize the combined first premix composition and second premix composition, and
wherein the pharmaceutical composition is a suspension and the nitric oxide-releasing particles are dispersed in the suspension.
2. The method of claim 1 , wherein the composition is anhydrous.
3. The method of claim 2 , wherein the first excipient composition further comprises at least one humectant.
4. The method of claim 3 , wherein the second excipient composition comprises at least one humectant and/or at least one water repellant.
5. The method of claim 4 , wherein
the concentration of the viscosity agent in the pharmaceutical composition is in a range of 0.5 to 30 weight percent;
the concentration of the at least one API in the topical composition is in a range of 0.1 to 10 weight percent;
the concentration of the humectant in the topical composition is in a range of 2 to 20 weight percent; and
the concentration of the water repellant in the topical composition is in a range of 0.5 to 15 weight percent.
6. The method of claim 1 , wherein homogenizing the first excipient composition is performed at a rate in a range of 2,500 to 10,000 rpm.
7. The method of claim 1 , wherein
the first excipient composition is homogenized in a first vessel to form the first premix composition;
the at least one API and the second excipient composition are separately mixed in the first vessel to form the second premix composition; and
the first premix composition and the second premix composition are combined in a second vessel.
8. The method of claim 7 , wherein the first premix composition is transferred from the first vessel to the second vessel by a positive displacement pump at a transfer rate that avoids gelation.
9. The method of claim 7 , wherein homogenizing the first excipient composition comprises recirculating the first excipient composition through an in-line homogenizer.
10. The method of claim 1 , further comprising packaging the pharmaceutical composition.
11. The method of claim 1 , wherein homogenizing the first excipient composition comprises adding the at least one viscosity agent to the at least one solvent at a rate in a range of 0.5 to 50 g of the at least one viscosity agent per min per liter of the at least one solvent to form the first premix composition.
12. The method of claim 1 , wherein the pharmaceutical composition is in the form of a gel.
13. The method of claim 1 , wherein homogenizing the first excipient composition comprises homogenizing the first excipient composition at a first temperature in a range of 0° C. to 25° C., and homogenizing the combined first premix composition and second premix composition comprises homogenizing the combined first premix composition and second premix composition at a second temperature in a range of 0° C. to 25° C.
14. The method of claim 13 , wherein the first temperature is in a range of 0° C. to 22° C. and/or the second temperature is in a range of 0° C. to 22° C.